Related Experiment Videos
Gene expression microarray technologies in the development of new therapeutic agents
Paul A Clarke1, Robert te Poele, Paul Workman
1Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, UK.
European Journal of Cancer (Oxford, England : 1990)
|November 16, 2004
Summary
Gene expression microarray technology aids cancer therapeutic discovery and development. This gene profiling helps classify cancer, identify targets, and predict drug responses, improving patient selection and treatment outcomes.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- Gene expression microarray technology offers a global view of cellular activity.
- Understanding gene expression is crucial for advancing cancer therapeutics.
Purpose of the Study:
- To review the multifaceted benefits of gene expression microarray technology in cancer drug discovery and development.
- To highlight its applications across various stages, from target identification to clinical use.
Main Methods:
- Global gene expression profiling using microarrays.
- Integration with gene knockout/knockdown techniques like RNA interference.
- Analysis of basal/constitutive gene expression patterns.
Main Results:
- Gene expression profiling aids in cancer classification and pathway elucidation.
- It identifies potential therapeutic targets and predicts drug sensitivity/resistance.
- Molecular signatures of drug action, including on-target and off-target effects, can be defined.
Conclusions:
- Gene expression profiling is invaluable for cancer therapeutic discovery, development, and clinical application.
- It facilitates biomarker identification for proof-of-concept, pharmacodynamics, and patient stratification.
- This technology enhances the precision and efficacy of cancer treatments.